Advancing liver cancer treatment with dual-targeting CAR-T therapy | Journal of Nanobiotechnology
Expression analysis of AFP and GPC3 in liver cancerTo develop effective and safe CAR-T cell therapy for liver cancer, we...
Expression analysis of AFP and GPC3 in liver cancerTo develop effective and safe CAR-T cell therapy for liver cancer, we...
Credit: Hepatology (2025). DOI: 10.1097/HEP.0000000000001406 Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of...
New Delhi, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The global liver fibrosis treatment market was valued at USD 17.51 billion...
Comparative study process of LLMs and doctors in predicting immune therapy response for liver cancer. Credit: Wang Tengfei, from the...
BRIDGEPORT, W.Va. — By the time Eric Tennant was diagnosed in 2023 with a rare cancer of the bile ducts,...
Patients and healthcare providers are set to benefit from a new era in cancer treatment as the UK Government slashes...